NICE-recommended weight management strategies include: Dietary intervention aiming for a 600 kcal/day deficit through reduced portion sizes, limiting energy-dense foods, and increasing fruit and vegetable consumption Physical activity building up to 150300 minutes of moderate-intensity aerobic activity weekly, plus muscle-strengthening activities on at least two days weekly, in line with UK Chief Medical Officers' guidelines [10] Behavioural approaches including self-monitoring, goal-setting, and addressing emotional eating patterns Commercial weight management programmes such as those meeting NICE quality standards (QS127) Very-low-calorie diets in specific circumstances, under clinical supervision and for limited periods For patients with a BMI 30 kg/m (or 27.5 kg/m in those of South Asian, Chinese, or other Asian family origin) who have not achieved adequate weight loss through lifestyle measures alone, pharmacological interventions may be considered

Inflammatory modulation by KPV adds to the repair mechanisms of the other three components
Significant weight loss from GLP-1 therapy may reduce levothyroxine requirements in some patients
This causes several immune cells to be triggered, such as dendritic cells, macrophages, neutrophils, monocytes, and natural killer cells (142)
What the Research Says Scientific research is the foundation of peptide therapy, and studies consistently explore both the effectiveness and safety of these treatments